A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Ixazomib Citrate (S)-Isomer - Request Quote

Picture of Ixazomib Citrate (S)-Isomer

Ixazomib Citrate (S)-Isomer

SZ CAT No:SZ-I061014
CAS No
NA
Mol.F.
C20H23BCl2N2O9
Mol.Wt.
517.1
Inv. Status
In Stock

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Ixazomib Citrate (S)-Isomer is chemically (S)-2,2'-(2-(1-(2-(2,5-Dichlorobenzamido)acetamido)-3-methylbutyl)-5-oxo-1,3,2-dioxaborolane-4,4-diyl)diacetic acid. Ixazomib Citrate (S)-Isomer is supplied with detailed characterization data compliant with regulatory guideline. Ixazomib Citrate (S)-Isomer can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ixazomib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Ixazomib Citrate (S)-Isomer

Purchase Ixazomib Citrate (S)-Isomer

Ixazomib Citrate (S)-Isomer suppliers

Ixazomib Citrate (S)-Isomer manufacturers

Ixazomib Citrate (S)-Isomer price

Order Ixazomib Citrate (S)-Isomer

Enquire Ixazomib Citrate (S)-Isomer

Ixazomib Citrate (S)-Isomer cost

Ixazomib Citrate (S)-Isomer Supplier

Ixazomib Citrate (S)-Isomer Distributor

Ixazomib Citrate (S)-Isomer for Method Validation

Ixazomib Reference Standard

Ixazomib Citrate (S)-Isomer for ANDA Filing

Ixazomib Citrate (S)-Isomer for Forced Degradation Studies

Ixazomib Citrate (S)-Isomer Identification Standards

Ixazomib Citrate (S)-Isomer for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,